Cholesterol is an essential plasma membrane
lipid for the maintenance of cellular homeostasis and
cancer cell proliferation. Free
cholesterol is harmful to cells; therefore, excessive free
cholesterol must be quickly esterified by
acetyl-coenzyme A:
cholesterol acetyltransferase (ACAT) and exported by
scavenger receptor class B member I (SR-BI) or
ATP-binding cassette
protein A1 from specific cells such as macrophage foam cells, which contain
cholesteryl ester-derived vacuoles. Many vacuoles are present in the cytoplasm of
Burkitt lymphoma cells. In this study, we observed that these vacuoles are often seen in
high-grade lymphomas. Cell culture study using
lymphoma cell lines found that esterified
cholesterol is the main component of these vacuoles and the expression of
cholesterol metabolism-related molecules was significantly upregulated in
lymphoma cell lines, with SR-BI and ACAT inhibitors (BLT-1 and
CI-976, respectively) impeding
lymphoma cell proliferation. Cytoplasmic free
cholesterol was increased by ACAT and SR-BI inhibitors, and the accumulation of free
cholesterol induced
lymphoma cell apoptosis by inducing endoplasmic reticulum stress. Furthermore, synergistic effects of SR-BI and ACAT inhibitors were observed in a preclinical study. Treatment with SR-BI inhibitor suppressed
lymphoma progression in a
tumor-bearing mouse model, whereas ACAT inhibitor did not. Therefore, SR-BI inhibitors are potential new antilymphoma
therapeutics that target
cholesterol metabolism.